This week, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, joins us to discuss his new brief exploring how forthcoming restrictions in a state program serving dual-eligible Medicare and Medi-Cal enrollees will hurt patients. He discusses how the movement in government both in California and nationally limiting choice will limit access to care, increase costs to taxpayers and worsen health outcomes.
Listen on these platforms:
Share this episode:
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
